Empagliflozin 25mg Tbl ( DrugBank: Empagliflozin )


1 disease
IDDisease name (Link within this page)Number of trials
72Pituitary ADH secretion disorder1

72. Pituitary ADH secretion disorder


Clinical trials : 40 Drugs : 28 - (DrugBank : 7) / Drug target genes : 5 - Drug target pathways : 9
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02729766
(ClinicalTrials.gov)
March 201624/3/2016Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE StudyEffects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE StudyInappropriate ADH SyndromeOther: Induced hypotonic hyponatremia - SIAD model;Drug: Empagliflozin 25mg Tbl;Drug: Placebo P-TabletUniversity Hospital, Basel, SwitzerlandNULLCompleted18 Years65 YearsBoth15Phase 2/Phase 3Switzerland